What Makes Us Unique

  • SpermoCheck Combo is the world’s first quantitative Point-of-Care Test (POCT) that simultaneously measures sperm count and sperm motility using the innovative biomarker TEX101. This unique approach sets us apart from traditional semen analysis, offering faster, more reliable, and actionable results.
  • We provide a comprehensive fertility evaluation for men by measuring both sperm count and sperm motility in a single test, giving a complete picture of male fertility with just one sample.
  • TEX101, a testicular germ cell-specific protein, is used to assess sperm motility—something no other fertility test has done with such precision. This biomarker has been shown to play a crucial role in sperm migration and fertilization, making it a game-changer in male fertility diagnostics.

Our tests deliver quantitative results within 10 minutes, ensuring rapid decision-making and quicker access to fertility insights, compared to traditional, time-consuming tests.

  • We simplify the testing process by requiring only 50 µL of seminal plasma for SpermoCheck Combo and small samples for female fertility tests. This makes the procedure less invasive and more convenient for patients.
  • SpermoCheck Combo offers 81% sensitivity and 100% specificity in distinguishing between obstructive and non-obstructive azoospermia (OA vs. NOA), ensuring highly accurate diagnosis with minimal risk of false results.
  • We provide comprehensive fertility solutions for both men and women, offering AMH/FSH Combo for female fertility assessment alongside SpermoCheck Combo for male fertility, allowing couples to gain insights into both partners’ fertility health in a streamlined manner.
  • Our POCT solutions make fertility testing affordable, accessible, and portable, empowering individuals to take charge of their reproductive health without the need for expensive, laboratory-based tests or long waiting times.
  • We prioritize environmental sustainability by using bio-inert, eco-friendly materials in our test kits, reducing medical waste and promoting greener healthcare solutions.
  • Our tests are supported by AI-powered analytics, providing clear, detailed, and easy-to-understand reports that guide healthcare professionals and patients through their fertility health journey.
  • SpermoCheck Combo is the first-ever clinical-grade test using TEX101 for male fertility screening, providing unique applications in diagnosing infertility types, predicting sperm retrieval success, and evaluating post-vasectomy results.
  • Unlike traditional tests that require large, complex samples, our products require only small volumes of semen or blood, streamlining the testing process and making it easier for patients to undergo fertility assessments.